home / stock / czo:cc / czo:cc news

CZO:CC News and Press, Ceapro Inc. From 06/07/22

Stock Information
Company Name: Ceapro Inc.
Stock Symbol: CZO:CC
Market: TSXVC
Website: ceapro.com
Menu
CZO:CC CZO:CC Quote CZO:CC Short CZO:CC News CZO:CC Articles CZO:CC Message Board
Get CZO:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
CZO:CC - Ceapro Announces Results of 2022 Shareholders' Meeting

EDMONTON, Alberta, June 07, 2022 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and co...
CZO:CC - Ceapro Inc. to Present at the H.C. Wainwright Global Investment Conference

EDMONTON, Alberta, May 23, 2022 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare...

CZO:CC - Ceapro Inc. Reports Record Financial Results for First Quarter 2022 and Provides Corporate Update

– Best quarterly financial results in history of the Company – Q1 2022 sales of $6,172,000 vs $4,702,000 in Q1 2021, a 31% increase – Operating profit of $2,614,000 in Q1 2022 vs $515,000 in Q1 2021 – Company responds to increased ...

CZO:CC - Ceapro Inc. Present PGX Enabling Technology Case Study at the 13th International Symposium on Supercritical Fluids

EDMONTON, Alberta, May 13, 2022 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare...
CZO:CC - Ceapro Inc. Announces Publication of Results for PGX-Processed Alginates in the Journal of CO2 Utilization

– Findings from the collaborative project with the University of Alberta illustrate broad potential of the PGX Technology to generate the next generation of bioactive delivery systems – PGX Technology successfully transforms brown algae alginates into fibrils w...

CZO:CC - Ceapro Inc. Announces Appointment of Geneviève Foster to Board of Directors

EDMONTON, Alberta, April 19, 2022 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO, OTCQX: CRPOF) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and c...

CZO:CC - Ceapro Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights

– FY 2021 record sales of $17,200,000 compared to $15,100,000 for FY 2020, representing a 14% increase year over year; Ceapro’s best sales performance in Company history – Net profit of $2,842,000 for the full year of 2021 compared to a net profit of...
Previous 10 Next 10